Dabomb Protein Biotech (ROCO:6578) ROE % Adjusted to Book Value: -12.65% (As of Dec. 2025)


ROCO:6578 Dabomb Protein Biotech Corp ROCO:6578
59 GF Score
Price NT$16.40
GF Value NT$14.53
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Dabomb Protein Biotech ROE % Adjusted to Book Value?

Dabomb Protein Biotech ROCO:6578 59 ROE % Adjusted to Book Value is -12.65% as of Dec. 2025. GuruFocus rates ROCO:6578 with a GF Score™ of 59/100 and a GF Value™ of NT$14.53 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Dabomb Protein Biotech's ROE % for the quarter that ended in Dec. 2025 was -17.58%. Dabomb Protein Biotech's PB Ratio for the quarter that ended in Dec. 2025 was 1.39. Dabomb Protein Biotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -12.65%.


Dabomb Protein Biotech ROE % Adjusted to Book Value Related Terms


Dabomb Protein Biotech ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech ROE % Adjusted to Book Value Chart

Dabomb Protein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.56 -7.32 -5.17 0.92 -4.80

Dabomb Protein Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.64 -4.31 -3.27 -12.65

ROCO:6578 vs KHC, GIS: ROE % Adjusted to Book Value Comparison

For the Packaged Foods subindustry, Dabomb Protein Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dabomb Protein Biotech ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Dabomb Protein Biotech's ROE % Adjusted to Book Value falls into.


ROCO:6578
59GF Score
Dabomb Protein Biotech Corp ROCO:6578
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dabomb Protein Biotech ROE % Adjusted to Book Value Calculation

Dabomb Protein Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.67% / 1.39
=-4.80%

Dabomb Protein Biotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-17.58% / 1.39
=-12.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -12.65% mean?
Dabomb Protein Biotech (ROCO:6578) has a ROE % Adjusted to Book Value of -12.65% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's ROE % Adjusted to Book Value too high?
Dabomb Protein Biotech's current ROE % Adjusted to Book Value is -12.65%. Overall, Dabomb Protein Biotech has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's ROE % Adjusted to Book Value compare to KHC and GIS?
Dabomb Protein Biotech's ROE % Adjusted to Book Value of -12.65% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current ROE % Adjusted to Book Value is -12.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.53, compared to a current price of NT$16.40 — trading 12.9% above its estimated fair value. The current ROE % Adjusted to Book Value is -12.65%. Dabomb Protein Biotech's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current ROE % Adjusted to Book Value is -12.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued. The current stock price of NT$16.40 is trading 12.9% above its estimated GF Value™ of NT$14.53. GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:6578:

  • ROE % Adjusted to Book Value: -12.65%
  • GF Value™: NT$14.53 vs. price of NT$16.40 (12.9% above fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dabomb Protein Biotech Business Description

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
59GF Score

Get the complete analysis for ROCO:6578

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.40
Price
NT$14.53
GF Value